Investing in healthcare stocks may be rewarding, especially when the healthcare sector is rapidly expanding with the rise of healthcare stocks in India. Investors are keen to identify the top healthcare stocks in India to add to their equity portfolio management strategies.
Healthcare stocks have always been considered a haven during market volatility because the demand for healthcare services does not diminish, even during economic downturns. This factor could make the top healthcare stocks in India not just a defensive play but a proactive growth strategy.
The Diverse Anatomy of Healthcare Sector Stocks in India
The healthcare sector stocks in India are diverse, ranging from pharmaceutical companies to hospital chains and healthcare service providers. This diversity allows for a robust investment advisory approach, catering to different risk appetites and investment horizons.
Investment advisory services often highlight the importance of including healthcare stocks in a balanced portfolio. They provide the necessary guidance to navigate the complexities of the market and help identify the best healthcare stocks in India that offer both growth and stability.
Top Healthcare Stocks in India
Here’s a list of 5 prominent healthcare stocks in India that are known for their market presence and growth potential:
- Apollo Hospitals Enterprise Ltd: This healthcare stock opened at ₹6,140.00 on 20th April 2024. The healthcare stock’s trading volume was 5,60,178 shares, boasting a market cap of ₹88,708 Cr., signifying its robust position among healthcare stocks. With a beta of 0.78, Apollo Hospitals shows less volatility than the market.
Apollo Hospitals reported revenue from operations at ₹16,612 Cr. and a net profit of ₹844.3 Cr in FY23. This stock’s debt-to-equity ratio of 0.41 indicates a balanced approach to financing.
The PE ratio for this healthcare stock stood at a lofty 75.67, and the PB ratio was 10.00, suggesting a growth-oriented valuation typical of healthcare stocks. The dividend yield of 0.24% may seem modest, but it reflects the typical reinvestment strategy of growth-focused healthcare stocks.
Overall, Apollo Hospitals Enterprise Ltd. encapsulates the characteristics of a growth-oriented healthcare stock with a strong market presence and promising financial performance.
| Metric | All-Time High |
| Open | ₹6,140.00 |
| Previous Close | ₹6,074.15 |
| Volume | 5,60,178 |
| Value (Lacs) | ₹34,560.46 |
| VWAP | ₹6,135.87 |
| Beta | 0.78 |
| Mkt Cap (Rs. Cr.) | ₹88,708 |
| High | ₹6,199.00 |
| Low | ₹6,050.00 |
| UC Limit | ₹6,681.55 |
| LC Limit | ₹5,466.75 |
| 52 Week High | ₹6,874.45 |
| 52 Week Low | ₹4,221.55 |
| Face Value | ₹5 |
| All Time High | ₹6,874.45 |
| All Time Low | ₹27.00 |
| 20D Avg Volume | 4,57,258 |
| 20D Avg Delivery(%) | 54.72% |
| Book Value Per Share | ₹410.30 |
| Dividend Yield | 0.24% |
| Revenue 2024 | ₹16,612 Cr. |
| Net Profit 2024 | ₹887 Cr. |
| Debt to Equity | 0.44 |
| PE ratio March 2024 | 75.67 |
| PB ratio March 2024 | 10.00 |
- Max Healthcare Institute Ltd: a healthcare stock, opened at ₹779.00 on 20th April 2024, a slight increase from the previous close of ₹778.10. This healthcare stock saw a trading volume of 19,11,786 shares with a market cap of ₹75,110 Cr., marking its presence in the healthcare industry. The healthcare stock’s beta of 0.40 indicates lower volatility. Financially, this healthcare stock reported revenue from operations of ₹4,562 Cr. and a net profit of ₹1,103 Cr. in FY23.
With a debt-to-equity ratio of 0.09, Max Healthcare shows prudent financial management. This healthcare stock’s PE ratio was 69.9, and the PB ratio was 7.2, reflecting a solid valuation among healthcare stocks. Although the dividend yield is not provided, the financial metrics suggest that Max Healthcare has a strong financial foundation and potential for growth.
| Metric | Value |
| Open | ₹779.00 |
| Previous Close | ₹778.10 |
| Volume | 19,11,786 |
| Value (Lacs) | ₹14,775.24 |
| VWAP | ₹766.75 |
| Beta | 0.40 |
| Mkt Cap (Rs. Cr.) | ₹75,110 |
| High | ₹779.55 |
| Low | ₹748.45 |
| UC Limit | ₹933.70 |
| LC Limit | ₹622.50 |
| 52 Week High | ₹910.00 |
| 52 Week Low | ₹411.90 |
| Face Value | ₹10 |
| All Time High | ₹910.00 |
| All Time Low | ₹0.00 |
| 20D Avg Volume | 21,50,296 |
| 20D Avg Delivery(%) | – |
| Book Value Per Share | ₹64.79 |
| Dividend Yield | – |
| Revenue 2024 | ₹4,562 Cr. |
| Net Profit 2024 | ₹1,103 Cr. |
| Debt to Equity | 0.08 |
| PE ratio March 2024 | 38.76 |
| PB ratio March 2024 | 5.78 |
- Fortis Healthcare Ltd: A key healthcare stock is an integrated healthcare services provider in India and one of the largest healthcare organizations in the country. With a network of 28 healthcare facilities, Fortis is known for its world-class patient care and clinical excellence. On 20th April 2024, the healthcare stock opened and closed at ₹436.05, with a trading volume of 4,42,141 shares and a market cap of ₹32,478 Cr. The healthcare stock’s beta of 0.42 suggests lower volatility, indicative of a stable investment within the healthcare sector.
Financially, Fortis Healthcare, as a healthcare stock, reported a revenue of ₹6,298 Cr. and a net profit of ₹633 Cr. for FY23. The debt-to-equity ratio stood at a conservative 0.09, showing minimal debt reliance. The PE ratio was 62.8, and the PB ratio was 4.4, reflecting a solid valuation among healthcare stocks. The dividend yield was 0.23%, indicating a modest income return for investors. This overview highlights Fortis Healthcare Ltd. as a prominent healthcare stock with a strong market presence and a commitment to high-quality healthcare delivery.
| Metric | All-Time High |
| Open | ₹436.05 |
| Previous Close | ₹436.05 |
| Volume | 4,42,141 |
| Value (Lacs) | ₹1,902.09 |
| VWAP | ₹431.26 |
| Beta | 0.42 |
| Mkt Cap (Rs. Cr.) | ₹32,478 |
| High | ₹436.05 |
| Low | ₹425.00 |
| UC Limit | ₹523.25 |
| LC Limit | ₹348.85 |
| 52 Week High | ₹469.70 |
| 52 Week Low | ₹253.25 |
| Face Value | ₹10 |
| All Time High | ₹469.70 |
| All Time Low | ₹46.10 |
| 20D Avg Volume | 11,40,997 |
| 20D Avg Delivery(%) | – |
| Book Value Per Share | ₹92.83 |
| Dividend Yield | 0.23% |
| Revenue 2024 | ₹6,297 Cr. |
| Net Profit 2024 | ₹611 Cr. |
| Debt to Equity | 0.1 |
| PE ratio March 2024 | 33.32 |
| PB ratio March 2024 | 2.71 |
- Global Health Ltd.: Global Health Ltd., a healthcare stock, is recognized for its multi-super specialty institute that provides a range of healthcare services, including cardiology, anesthesiology, and oncology, among others. Opening at ₹1,332.35 on 20th April 2024, this healthcare stock experienced a trading volume of 1,54,489 shares, with a market cap of ₹37,690 Cr. The healthcare stock’s beta of 0.41 indicates stability and is less volatile than the broader market.
In the financial year 2023, Global Health Ltd. reported a consolidated revenue of ₹2,694.24 Cr. and a net profit of ₹326 Cr. The healthcare stock maintained a low debt-to-equity ratio of 0.35, reflecting sound financial management. The PE ratio was 51.87, and the PB ratio was 5.67, suggesting a growth-oriented valuation for this healthcare stock. Although the dividend yield has not been reported, the financials indicate that Global Health Ltd. may grow and have a strong presence in the healthcare industry.
| Metric | All-Time High |
| Open | ₹1,332.35 |
| Previous Close | ₹1,372.95 |
| Volume | 1,54,489 |
| Value (Lacs) | ₹2,168.56 |
| VWAP | ₹1,391.47 |
| Beta | 0.41 |
| Mkt Cap (Rs. Cr.) | ₹37,690 |
| High | ₹1,409.00 |
| Low | ₹1,332.35 |
| UC Limit | ₹1,647.50 |
| LC Limit | ₹1,098.40 |
| 52 Week High | ₹1,513.90 |
| 52 Week Low | ₹478.05 |
| Face Value | ₹2 |
| All Time High | ₹1,513.90 |
| All Time Low | ₹0.00 |
| 20D Avg Volume | 3,32,579 |
| 20D Avg Delivery(%) | – |
| Book Value Per Share | ₹92.69 |
| Dividend Yield | – |
| Revenue 2023 | ₹1,959 Cr. |
| Net Profit 2023 | ₹263 Cr. |
| Debt to Equity | 0.35 |
| PE ratio March 2023 | 51.87 |
| PB ratio March 2023 | 5.67 |
- Narayana Hrudayalaya Ltd.: Narayana Hrudayalaya Ltd. is a healthcare stock. It is a prominent healthcare provider known for its extensive network of hospitals offering a wide range of medical services. Opening at ₹1,238.45 on 20th April 2024, this healthcare stock traded 1,74,736 shares with a market cap of ₹25,390 Cr. The healthcare stock’s beta of 0.55 suggests moderate volatility.
Financially, the healthcare stock reported an operating revenue of ₹4,524 Cr. and a net profit of ₹606 Cr. for FY2023. With a debt-to-equity ratio of 0.37, Narayana Hrudayalaya maintains a balanced financial structure. The PE ratio of this healthcare stock was 25.93, and the PB ratio was 7.42, indicating a fair valuation in the healthcare market. The dividend yield of 0.20% reflects a modest income return for investors.
| Metric | Value |
| Open | ₹3,838.00 |
| Previous Close | ₹3,862.00 |
| Volume | 29,57,749 |
| Value (Lacs) | ₹1,13,169.39 |
| VWAP | ₹3,827.74 |
| Beta | 0.82 |
| Mkt Cap (Rs. Cr.) | 13,85,084 |
| High | ₹3,852.55 |
| Low | ₹3,800.90 |
| UC Limit | ₹4,248.20 |
| LC Limit | ₹3,475.80 |
| 52 Week High | ₹4,254.75 |
| 52 Week Low | ₹3,005.00 |
| Face Value | ₹1 |
| All Time High | ₹4,254.75 |
| All Time Low | ₹103.84 |
| 20D Avg Volume | 33,59,572 |
| 20D Avg Delivery(%) | – |
| Book Value Per Share | ₹245.54 |
| Dividend Yield | 1.91% |
| Revenue 2024 | ₹240,893 Cr. |
| Net Profit 2024 | ₹46,099 Cr. |
| Debt to Equity | 0.37 |
| PE ratio March 2024 | 30.79 |
| PB ratio March 2024 | 15.54 |
Equity Portfolio Management: The Backbone of Investment
Equity portfolio management is key when investing in healthcare stocks. It involves a strategic allocation of assets to maximize returns while minimizing risks. The top healthcare stocks in India have shown resilience and consistent performance, making them an essential component of a well-managed equity portfolio.
Incorporating practices like yoga for financial health can also be beneficial. It may seem unconventional, but the mindfulness achieved through yoga can lead to clearer thinking and better decision-making when it comes to personal finance and investments.
Lastly, knowing how to improve finance is crucial for any investor. It’s not just about picking the right stocks but also about financial planning and understanding the market dynamics that affect healthcare stocks.
Conclusion
In conclusion, healthcare stocks are an essential part of an investor’s portfolio, especially in the Indian market. You can leverage the healthcare sector’s growth potential with the right investment advisory and equity portfolio management. Remember, a calm mind through practices like yoga can also contribute to financial health and improved decision-making in finance.
Know more about
IPO | Current IPO | Upcoming IPO | Listed IPO
*Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as recommendation or investment advice by Research & Ranking. We will not be liable for any losses that may occur. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.
FAQs
Are healthcare stocks defensive?
Yes, healthcare stocks are generally considered defensive. They tend to provide stable earnings and dividends, which can offer a buffer during market downturns because the demand for healthcare services remains consistent regardless of the economy’s strength. However, it’s important to note that not all healthcare stocks may be defensive, and the sector’s composition has evolved over time, with a growing influence from biotech and medical technology companies.
Are healthcare stocks undervalued?
There is a perspective among some analysts and hedge funds that healthcare stocks are currently undervalued. Over 50% of healthcare stocks have been rated 4 or 5 stars, indicating they trade below the overall estimate of their intrinsic value. This suggests that, despite the sector’s recent underperformance, there may be attractive investment opportunities in healthcare stocks.
Will healthcare stocks rebound?
After a period of adjustment post-COVID, the sector is entering the new year with compressed valuations just as innovation picks up. This, combined with long-term demographic trends and medical advances, positions the sector for potential growth and a recovery in earnings.
I’m Archana R. Chettiar, an experienced content creator with
an affinity for writing on personal finance and other financial content. I
love to write on equity investing, retirement, managing money, and more.